Readiness to Change and Prospective Effects of Weight Management Programs in Pediatric Nonalcoholic Fatty Liver Disease
- PMID: 33142354
- PMCID: PMC7993262
- DOI: 10.1111/cts.12913
Readiness to Change and Prospective Effects of Weight Management Programs in Pediatric Nonalcoholic Fatty Liver Disease
Abstract
Non-alcoholic fatty liver disease (NAFLD) is an increasing problem in pediatrics with limited treatment options. We prospectively assessed outcomes in patients managed in a hepatology clinic (HC) alone vs. those managed in combination with a multidisciplinary weight management program (MWMP). We describe each group's readiness to change at the time of NAFLD diagnosis. Patients diagnosed with NAFLD were given a modified Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) at enrollment (T1) to assess readiness to change. They were then followed at 3-9 months (T2) and at 10-15 months (T3). Linear mixed models were used to evaluate changes in body mass index (BMI), BMI z-score, and transaminases over time and between the two groups. There were no significant treatment group main effects or treatment × time interactions for our primary end points for HC alone (n = 75) or with MWMP (n = 18). There was a significant main effect for time for BMI z-score, with BMI z-scores declining on average by 0.0568 (P = 0.004) from visit to visit. Low SOCRATES subscales scores in HC alone (n = 33) or with MWMP (n = 4) suggested a patient population with low recognition of disease and likelihood of taking steps for change. Patients with obesity and NAFLD had low scores on all three SOCRATES subscales. Despite this, both groups had improvement in BMI z-score without significant difference between the two treatment groups in other primary end points. Further study is needed to identify the most effective patient selection and treatment strategies for pediatric patients with NAFLD, including pharmacotherapy and surgery.
© 2020 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of the American Society for Clinical Pharmacology and Therapeutics.
Conflict of interest statement
All authors declared no competing interests for this work.
Figures
Similar articles
-
Body mass index in school-aged children and the risk of routinely diagnosed non-alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records Register.BMJ Open. 2015 May 3;5(4):e006998. doi: 10.1136/bmjopen-2014-006998. BMJ Open. 2015. PMID: 25941179 Free PMC article.
-
Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.Nutrients. 2018 Sep 19;10(9):1329. doi: 10.3390/nu10091329. Nutrients. 2018. PMID: 30235828 Free PMC article.
-
Readiness for behaviour change in non-alcoholic fatty liver disease: implications for multidisciplinary care models.Liver Int. 2015 Mar;35(3):936-43. doi: 10.1111/liv.12483. Epub 2014 Mar 10. Liver Int. 2015. PMID: 24521540 Free PMC article.
-
The Effectiveness of Nutrition Specialists on Pediatric Weight Management Outcomes in Multicomponent Pediatric Weight Management Interventions: A Systematic Review and Exploratory Meta-Analysis.J Acad Nutr Diet. 2019 May;119(5):799-817.e43. doi: 10.1016/j.jand.2018.12.008. Epub 2019 Mar 2. J Acad Nutr Diet. 2019. PMID: 30833172
-
Psychosocial Issues in Pediatric Nonalcoholic Fatty Liver Disease.Psychosomatics. 2019 Jan-Feb;60(1):10-17. doi: 10.1016/j.psym.2018.09.001. Epub 2018 Sep 8. Psychosomatics. 2019. PMID: 30318268 Review.
Cited by
-
Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges.Ther Adv Endocrinol Metab. 2023 Mar 22;14:20420188231160388. doi: 10.1177/20420188231160388. eCollection 2023. Ther Adv Endocrinol Metab. 2023. PMID: 36968656 Free PMC article. Review.
-
Leukocyte cell-derived chemotaxin 2 correlates with pediatric non-alcoholic fatty liver disease.Clin Transl Sci. 2023 Dec;16(12):2719-2728. doi: 10.1111/cts.13666. Epub 2023 Oct 27. Clin Transl Sci. 2023. PMID: 37877453 Free PMC article.
-
Proteomics Used in Identifying Novel Correlates of Disease in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease.Clin Transl Sci. 2025 Jun;18(6):e70271. doi: 10.1111/cts.70271. Clin Transl Sci. 2025. PMID: 40522163 Free PMC article.
References
-
- Skinner, A.C. , Ravanbakht, S.N. , Skelton, J.A. , Perrin, E.M. , Armstrong, S.C. Prevalence of obesity and severe obesity in US children, 1999‐2016 [published correction appears in Pediatrics. 2018 Sep;142(3)]. Pediatrics 141, e20173459 (2018). - PubMed
-
- Hales, C.M. , Carroll, M.D. , Fryar, C.D. & Ogden, C.L. Prevalence of obesity among adults and youth: United States, 2015–2016. NCHS Data Brief 288, 1–8 (2017). - PubMed
-
- Baranowski, T. , Motil, K.J. & Moreno, J.P. Multi‐etiological perspective on child obesity prevention. Curr. Nutr. Rep. https://doi.org/10.1007/s13668-019-0256-3. - DOI - PMC - PubMed
-
- Reilly, J.J. & Kelly, J. Long‐term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review. Int. J. Obes. (Lond). 35, 891–898 (2011). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical